ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 120 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $17,361,000 | -37.0% | 398,194 | -42.9% | 0.61% | -36.1% |
Q1 2018 | $27,539,000 | -46.8% | 697,194 | -54.2% | 0.95% | -53.1% |
Q4 2017 | $51,722,000 | +89.2% | 1,522,566 | +42.0% | 2.04% | +65.3% |
Q3 2017 | $27,344,000 | +289.0% | 1,072,329 | +157.3% | 1.23% | +228.5% |
Q2 2017 | $7,030,000 | – | 416,729 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |